Searches , social queries for 5 APDI

Search references for 5 APDI. Phrases containing 5 APDI

See searches and references containing 5 APDI!

Searches containing 5 APDI

5 APDI

  • 5-APDI
  • Chemical compound

    5-(2-Aminopropyl)-2,3-dihydro-1H-indene (5-APDI), also known as indanylaminopropane (IAP), 2-aminopropylindane (2-API), indanametamine, and, incorrectly

    5-APDI

    5-APDI

    5-APDI

  • Entactogen
  • Class of psychoactive drugs that produce empathic experiences

    (MDxx) MDMA, MDA, MDEA, MDOH, MBDB, and methylone, the benzofurans 5-APB, 5-MAPB, 6-APB, and 6-MAPB, the cathinone mephedrone, the 2-aminoindane MDAI

    Entactogen

    Entactogen

    Entactogen

  • 5-MAPB
  • Chemical compound

    serotonin 5-HT1B, 5-HT2A, 5-HT2B, and 5-HT2C receptors. Some notable analogues of 5-MAPB besides MDMA include other benzofurans like 5-APB, 5-MAPDB, and

    5-MAPB

    5-MAPB

    5-MAPB

  • Bufotenin
  • Psychedelic drug found in toads, mushrooms and plants

    Bufotenin, also known as dimethylserotonin or as 5-hydroxy-N,N-dimethyltryptamine (5-HO-DMT), is a serotonergic psychedelic of the tryptamine family.

    Bufotenin

    Bufotenin

    Bufotenin

  • 1,4-Dimethylamylamine
  • Pharmaceutical compound

    4-Dimethylamylamine (1,4-DMAA), also known as 1,4-dimethylpentylamine or as 5-methylhexan-2-amine, is a stimulant drug of the alkylamine family related

    1,4-Dimethylamylamine

    1,4-Dimethylamylamine

    1,4-Dimethylamylamine

  • Lisdexamfetamine
  • Central nervous system stimulant prodrug

    earliest for d-MPH-ER at 0.5 hours, followed by d, l-MPH-LA at 1 to 2 hours, MCD at 1.5 hours, d, l-MPH-OR at 1 to 2 hours, MAS-XR at 1.5 to 2 hours, MTS at 2

    Lisdexamfetamine

    Lisdexamfetamine

    Lisdexamfetamine

  • Pseudoephedrine
  • Synthetic decongestant

    average is 5.4 hours and ranges from 3 to 16 hours depending on urinary pH. At a pH of 5.6 to 6.0, the elimination half-life of pseudoephedrine was 5.2 to 8

    Pseudoephedrine

    Pseudoephedrine

    Pseudoephedrine

  • Amantadine
  • Medication used to treat dyskinesia

    catecholamines and serotonin in the brain". Bioorg Med Chem. 9 (5): 1197–1212. doi:10.1016/s0968-0896(01)00002-5. PMID 11377178. Knoll J, Yoneda F, Knoll B, Ohde H

    Amantadine

    Amantadine

    Amantadine

  • 3-Methylmethcathinone
  • Substituted cathinone designer drug

    properties compared to mephedrone or MDMA. 3-MMC binds to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, although it is unknown what impact this activity

    3-Methylmethcathinone

    3-Methylmethcathinone

    3-Methylmethcathinone

  • 5-MAPDI
  • Chemical compound

    5-MAPDI (also known as Indanylmethylaminopropane or IMP) is an entactogenic amphetamine derivative which is structurally related to MDMA as well as to

    5-MAPDI

    5-MAPDI

    5-MAPDI

  • Methylhexanamine
  • Chemical compound

    acute overdosage. The LD50 for methylhexanamine is 39 mg/kg in mice and 72.5 mg/kg in rats, when administered intravenously. The FDA has stated that methylhexanamine

    Methylhexanamine

    Methylhexanamine

    Methylhexanamine

  • Methamphetamine
  • Central nervous system stimulant

    methamphetamine at doses 5–10 mg/day for ADHD in adults and children over six years of age, which may be increased at weekly intervals of 5 mg, up to 25 mg/day

    Methamphetamine

    Methamphetamine

    Methamphetamine

  • Cyclazodone
  • Chemical compound

    List of aminorex analogues US 3321470, Howell Jr CF, Hardy RA, Quinones N, "5-Arylidene-2-Amino-2-Oxazolin-4-Ones", issued 23 May 1967, assigned to American

    Cyclazodone

    Cyclazodone

    Cyclazodone

  • 5-MAPDB
  • Chemical compound

    5-MAPDB, also known as 5-(2-(methylamino)propyl)-2,3-dihydrobenzofuran, is an entactogen of the dihydrobenzofuran family. It is structurally related to

    5-MAPDB

    5-MAPDB

    5-MAPDB

  • Levomethamphetamine
  • Topical nasal decongestant

    single intravenous doses of 0.25 to 0.5 mg/kg. The volume of distribution of levomethamphetamine is 288.5 to 315.5 L or 4.15 to 4.17 L/kg. The pharmacokinetics

    Levomethamphetamine

    Levomethamphetamine

    Levomethamphetamine

  • Phenylpiperazine
  • Chemical compound

    amphetamine: 2-amino-1,2-dihydronaphthalene". Journal of Medicinal Chemistry. 25 (5): 535–538. doi:10.1021/jm00347a011. PMID 6123601. "1-Phenylpiperazine". pubchem

    Phenylpiperazine

    Phenylpiperazine

    Phenylpiperazine

  • Cathinone
  • Chemical compound

    plasma is reached. The mean residence time is 5.2 ± 3.4 hours. The elimination half-life of cathinone is 1.5 ± 0.8 hours. A two-compartment model for absorption

    Cathinone

    Cathinone

    Cathinone

  • Phenmetrazine
  • Chemical compound

    Comparison of the DA, 5-HT, and NE Releasing Activity of a Series of Phenmetrazine Analogs [...] Table 5. Comparison of the DA, 5-HT, and NE Releasing

    Phenmetrazine

    Phenmetrazine

    Phenmetrazine

  • Tyramine
  • Trace amine

    behavior in locust phase changes". Scientific Reports. 5 (1). Nature/Springer: 8036. Bibcode:2015NatSR...5.8036M. doi:10.1038/srep08036. PMC 5389030. PMID 25623394

    Tyramine

    Tyramine

    Tyramine

  • Ephedrine
  • Medication, stimulant and decongestant

    available over-the-counter in the form of 12.5 and 25 mg oral tablets for use as a bronchodilator and as a 0.5% concentration nasal spray for use as a decongestant

    Ephedrine

    Ephedrine

    Ephedrine

  • Dextroamphetamine
  • CNS stimulant and isomer of amphetamine

    Retrieved 5 January 2017. "ProCentra (dextroamphetamine sulfate 5 mg/5 mL Oral Solution)". FSC Laboratories. Archived from the original on 5 October 2010

    Dextroamphetamine

    Dextroamphetamine

    Dextroamphetamine

  • Dimethyltryptamine
  • Psychedelic drug

    receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT6, and 5-HT7. An agonist action has been determined at 5-HT1A, 5-HT2A and 5-HT2C. Its efficacies

    Dimethyltryptamine

    Dimethyltryptamine

    Dimethyltryptamine

  • Isocyclamine
  • Pharmaceutical compound

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Isocyclamine

    Isocyclamine

    Isocyclamine

  • Methylenedioxypyrovalerone
  • Chemical compound

    intravenous use. It is supposedly active at doses of 3 to 5 mg, with typical doses ranging between 5 and 20 mg. The long-term effects of MDPV on humans have

    Methylenedioxypyrovalerone

    Methylenedioxypyrovalerone

    Methylenedioxypyrovalerone

  • Phenethylamine
  • Trace amine

    effects of exercise?". British Journal of Sports Medicine. 35 (5): 342–343. doi:10.1136/bjsm.35.5.342. PMC 1724404. PMID 11579070. The 24 hour mean urinary

    Phenethylamine

    Phenethylamine

    Phenethylamine

  • 2-APB (entactogen)
  • Pharmaceutical compound

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    2-APB (entactogen)

    2-APB (entactogen)

    2-APB_(entactogen)

  • 4-Methylaminorex
  • Group of stereoisomers

    4-Methylaminorex (4-MAR, 4-MAX) is a stimulant drug of the 2-amino-5-aryloxazoline group that was first synthesized in 1960 by McNeil Laboratories. It

    4-Methylaminorex

    4-Methylaminorex

    4-Methylaminorex

  • Adderall
  • Drug mixture used mainly to treat ADHD and narcolepsy

    amphetamine treatment for ADHD in children that found an average increase of 4.5 IQ points, continued increases in attention, and continued decreases in disruptive

    Adderall

    Adderall

    Adderall

  • Psilocybin
  • Chemical compound found in some species of mushrooms

    serotonin receptors. Activation of one serotonin receptor, the serotonin 5-HT2A receptor, is specifically responsible for the hallucinogenic effects

    Psilocybin

    Psilocybin

    Psilocybin

  • Cyclopentamine
  • Decongestant and stimulant drug

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Cyclopentamine

    Cyclopentamine

    Cyclopentamine

  • Serotonin–norepinephrine–dopamine releasing agent
  • Type of drug

    methamphetamine (in high doses), certain substituted benzofurans such as 5-APB and 6-APB, naphthylisopropylamine; cathinones such as mephedrone and methylone;

    Serotonin–norepinephrine–dopamine releasing agent

    Serotonin–norepinephrine–dopamine_releasing_agent

  • Methcathinone
  • Psychoactive stimulant

    for monoamine transporters in brain tissue". Neuropsychopharmacology. 37 (5): 1192–1203. doi:10.1038/npp.2011.304. PMC 3306880. PMID 22169943. Blough

    Methcathinone

    Methcathinone

    Methcathinone

  • Homo-MDMA
  • Pharmaceutical compound

    exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine". Pharmacol Biochem Behav. 38 (3): 505–512. doi:10

    Homo-MDMA

    Homo-MDMA

    Homo-MDMA

  • 5-Methoxytryptamine
  • Chemical compound

    5-Methoxytryptamine (5-MT, 5-MeO-T, or 5-OMe-T), also known as serotonin methyl ether or O-methylserotonin and as mexamine, is a tryptamine derivative

    5-Methoxytryptamine

    5-Methoxytryptamine

    5-Methoxytryptamine

  • Octodrine
  • Pharmaceutical compound

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Octodrine

    Octodrine

    Octodrine

  • Substituted amphetamine
  • Class of compounds based upon the amphetamine structure

    Synthesized Chemicals and Psychoactive Plants (First ed.). John Wiley & Sons. p. 5. ISBN 9781118106051. Retrieved 16 February 2019. PubChem. "Phenylpropanolamine"

    Substituted amphetamine

    Substituted amphetamine

    Substituted_amphetamine

  • Serotonin transporter
  • Mammalian protein found in humans

    The serotonin transporter (SERT or 5-HTT), also known as the sodium-dependent serotonin transporter and solute carrier family 6 member 4, is a protein

    Serotonin transporter

    Serotonin transporter

    Serotonin_transporter

  • Serotonin–norepinephrine releasing agent
  • Drug class

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Serotonin–norepinephrine releasing agent

    Serotonin–norepinephrine releasing agent

    Serotonin–norepinephrine_releasing_agent

  • Selegiline
  • Medication

    placebo decreased scores by 6.5 to 8.6 points, giving placebo-subtracted differences attributable to selegiline of 2.4 to 2.5 points. A 2013 quantitative

    Selegiline

    Selegiline

    Selegiline

  • MDMA
  • Psychoactive drug, often called ecstasy

    the serotonin 5-HT1 receptors, including the serotonin 5-HT1A, 5-HT1B, and 5-HT1D receptors, and is a partial agonist of the serotonin 5-HT2 receptors

    MDMA

    MDMA

    MDMA

  • Serotonin
  • Monoamine neurotransmitter

    serotonin 5-HT1 (1A, 1B, 1D, 1E, 1F), 5-HT2 (2A, 2B, 2C), 5-HT3, 5-HT4, 5-HT5 (5A, 5B), 5-HT6, and 5-HT7 receptors. Except for the serotonin 5-HT3 receptor

    Serotonin

    Serotonin

    Serotonin

  • 5-Fluorotryptamine
  • Pharmaceutical compound

    5-Fluorotryptamine (5-fluoro-T, 5-FT, or 5-F-T; code name PAL-284) is a serotonin receptor agonist and monoamine releasing agent of the tryptamine family

    5-Fluorotryptamine

    5-Fluorotryptamine

    5-Fluorotryptamine

  • Tuaminoheptane
  • Sympathomimetic agent

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Tuaminoheptane

    Tuaminoheptane

    Tuaminoheptane

  • Fenethylline
  • Codrug of amphetamine and theophylline

    captagon seizures estimated the drug's entire market to be worth at least $5.7bn. Smuggling of fenethylline became Syria's principal export, exceeding

    Fenethylline

    Fenethylline

    Fenethylline

  • 4-Benzylpiperidine
  • Chemical compound

    norepinephrine, with an EC50 of 109 nM (DA), 41.4 nM (NE), and 5,246 nM (5-HT). It also functions as a weak monoamine oxidase inhibitor (MAOI) (IC50Tooltip

    4-Benzylpiperidine

    4-Benzylpiperidine

    4-Benzylpiperidine

  • Serotonin releasing agent
  • Class of compounds

    (MDMA) 5-(2-Aminopropyl)benzofuran (5-APB) 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB) 5-Indanyl-2-aminopropane (IAP) 5-MABB 5-MAPB

    Serotonin releasing agent

    Serotonin releasing agent

    Serotonin_releasing_agent

  • Norepinephrine–dopamine releasing agent
  • Drug class

    genetic polymorphism of the enzyme CYP450 2D6. Under normal conditions, around 5 to 30% of amphetamine is excreted unchanged in the urine. However, the urinary

    Norepinephrine–dopamine releasing agent

    Norepinephrine–dopamine releasing agent

    Norepinephrine–dopamine_releasing_agent

  • 5-Methyltryptamine
  • Pharmaceutical compound

    serotonin 5-HT1A, 5-HT2B, 5-HT6, and 5-HT7 receptors, and an agonist of the serotonin 5-HT1D and 5-HT2C receptors. Similarly to tryptamine and 5-MeO-T, but

    5-Methyltryptamine

    5-Methyltryptamine

    5-Methyltryptamine

  • Propylhexedrine
  • Topical nasal decongestant

    adults and children 6–12 years of age. Each inhalation delivers 0.4 to 0.5 mg (400 to 500 μg) in 800 mL of air. Use is not to exceed three days. Historically

    Propylhexedrine

    Propylhexedrine

    Propylhexedrine

  • 5-EAPB
  • Chemical compound

    5-EAPB, also known as 5-(2-(ethylamino)propyl)benzofuran, is a potentially entactogenic amphetamine and benzofuran which is structurally related to 5-MAPB

    5-EAPB

    5-EAPB

    5-EAPB

  • Fenozolone
  • Group of stereoisomers

    Fluminorex Pemoline Thozalinone DE 1297108, Beil W, Hoeppener A, Wolff HJ, "5-phenyl-2-ethylamino-4-oxazolinone and its preparation", issued 12 June 1969

    Fenozolone

    Fenozolone

    Fenozolone

  • APA-01
  • Pharmaceutical compound

    predicted to interact with the monoamine transporters and with the serotonin 5-HT2 receptors. In contrast to MDMA, it does not produce hyperthermia in rodents

    APA-01

    APA-01

    APA-01

  • 1,3-Dimethylbutylamine
  • Chemical compound

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    1,3-Dimethylbutylamine

    1,3-Dimethylbutylamine

    1,3-Dimethylbutylamine

  • Phenylephrine
  • Decongestant medication

    contraindication to phenylephrine use. As a mydriatic, it is available in 2.5% and 10% eye drops. Phenylephrine eye drops are applied to the eye after a

    Phenylephrine

    Phenylephrine

    Phenylephrine

  • Phenylpropanolamine
  • Sympathomimetic agent

    administration. Immediate-release forms of the drug reached peak levels about 1.5 hours (range 1.0 to 2.3 hours) following administration. Conversely, extended-release

    Phenylpropanolamine

    Phenylpropanolamine

    Phenylpropanolamine

  • Methylenedioxybenzylpiperazine
  • Chemical compound

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Methylenedioxybenzylpiperazine

    Methylenedioxybenzylpiperazine

    Methylenedioxybenzylpiperazine

  • 3,4-Methylenedioxyamphetamine
  • Entactogen, stimulant, and psychedelic drug of the amphetamine family

    agent (SNDRA) and a serotonin 5-HT2 receptor agonist, including of the serotonin 5-HT2A receptor. It has a duration of 5 to 8 hours or around 6 hours typically

    3,4-Methylenedioxyamphetamine

    3,4-Methylenedioxyamphetamine

    3,4-Methylenedioxyamphetamine

  • MEAI
  • Chemical compound

    MEAI, also known as 5-methoxy-2-aminoindane (5-MeO-AI) and by its developmental code name CMND-100, is an entactogen-like psychoactive drug of the 2-aminoindane

    MEAI

    MEAI

    MEAI

  • MBDB
  • Chemical compound

    time-dependent hypothermia. MBDB has similar affinities for the serotonin 5-HT1A and 5-HT2A receptors as MDMA. However, MBDB did not show the head-twitch response

    MBDB

    MBDB

    MBDB

  • Mephedrone
  • Recreational drug

    significant affinity for various receptors, including the serotonin 5-HT2A, 5-HT2B, 5-HT2C, and α2-adrenergic receptors, as well as the trace amine-associated

    Mephedrone

    Mephedrone

    Mephedrone

  • 2-Methylmethcathinone
  • Stimulant designer drug of the substituted cathinone class

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    2-Methylmethcathinone

    2-Methylmethcathinone

    2-Methylmethcathinone

  • Cathine
  • Chemical compound

    Games among other athletic events) bans cathine in concentrations of over 5 micrograms per milliliter in urine. Cathine is a Schedule III drug under the

    Cathine

    Cathine

    Cathine

  • Methylbenzylpiperazine
  • Chemical compound

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Methylbenzylpiperazine

    Methylbenzylpiperazine

    Methylbenzylpiperazine

  • MDAI
  • Chemical compound

    notably includes the serotonin 5-HT2A receptor, which is implicated in producing psychedelic effects, and the serotonin 5-HT2B receptor, which is implicated

    MDAI

    MDAI

    MDAI

  • Phenylbutynamine
  • Pharmaceutical compound

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Phenylbutynamine

    Phenylbutynamine

    Phenylbutynamine

  • Phentermine
  • Weight loss medication

    inactive as a ligand or agonist of the serotonin 5-HT2 receptors, including of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors. This is in contrast to the

    Phentermine

    Phentermine

    Phentermine

  • Borax combo
  • Designer drug combination mimicking MDMA

    mixture of the entactogen 5-MAPB or MDAI, the stimulant 2-fluoromethamphetamine (2-FMA), and the serotonergic psychedelic 5-MeO-MiPT or 4-HO-MET, all

    Borax combo

    Borax combo

    Borax_combo

  • Monoamine transporter
  • Proteins that function as integral plasma-membrane transporters

    angiotensin II. SERT is responsible for the reuptake of extracellular serotonin (5-HT) in a Na +/Cl − -dependent process. In the CNS, SERT is found localized

    Monoamine transporter

    Monoamine transporter

    Monoamine_transporter

  • 6-CAT
  • Chemical compound

    and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA)". Journal of Medicinal Chemistry. 34 (5): 1662–8

    6-CAT

    6-CAT

    6-CAT

  • MDMAT
  • Entactogen drug

    (3T-MDMA; MY100) MY101 MY200 Indanes Amphetamines: 5-APDI (IAP) 5-MAPDI (IMP) Indoles Amphetamines: 5-API (5-IT; PAL-571) 6-API (6-IT) Naphthalenes Amphetamines:

    MDMAT

    MDMAT

    MDMAT

  • 4-Bromomethcathinone
  • Psychoactive drug and research chemical

    (3T-MDMA; MY100) MY101 MY200 Indanes Amphetamines: 5-APDI (IAP) 5-MAPDI (IMP) Indoles Amphetamines: 5-API (5-IT; PAL-571) 6-API (6-IT) Naphthalenes Amphetamines:

    4-Bromomethcathinone

    4-Bromomethcathinone

    4-Bromomethcathinone

  • Phenylpropylamine
  • Pharmaceutical compound

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Phenylpropylamine

    Phenylpropylamine

    Phenylpropylamine

  • Dopamine releasing agent
  • Type of drug

    MDMA and mephedrone, and serotonin–dopamine releasing agents (SDRAs) like 5-chloro-αMT and BK-NM-AMT, are known. A closely related type of drug is a dopamine

    Dopamine releasing agent

    Dopamine releasing agent

    Dopamine_releasing_agent

  • 5-MeO-DiPT
  • Psychedelic tryptamine

    4-MeO-DiPT, 5-HO-DiPT, 5-MeO-DMT, 5-MeO-DET, 5-MeO-DPT, 5-MeO-DALT, 5-MeO-MiPT, 5-MeO-MsBT, 5-MeO-EiPT, 5-MeO-PiPT, 5-MeO-iPALT (ASR-3001), and 5-MeO-DiBF

    5-MeO-DiPT

    5-MeO-DiPT

    5-MeO-DiPT

  • 5-Chlorotryptamine
  • Pharmaceutical compound

    It is the 5-chloro derivative of tryptamine. The drug shows affinity for the serotonin 5-HT1A, 5-HT2A, 5-HT6, and 5-HT7 receptors (Ki = 5.5–16 nM, 317–889 nM

    5-Chlorotryptamine

    5-Chlorotryptamine

    5-Chlorotryptamine

  • PiHKAL
  • 1991 book by Alexander Shulgin and Ann Shulgin

    (3-methyl-DOM) Hecate (DOET; 4-desmethyl-4-ethyl-DOM) Iris (5-desmethoxy-5-ethoxy-DOM; DOM-5-EtO) Juno (6-methyl-DOM) As with the essential amphetamines

    PiHKAL

    PiHKAL

  • Amfepentorex
  • Anorectic stimulant drug

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Amfepentorex

    Amfepentorex

    Amfepentorex

  • PAL-335
  • Pharmaceutical compound

    228563)". The Journal of Pharmacology and Experimental Therapeutics. 393 (5) 104268. doi:10.1016/j.jpet.2026.104268. Bloom NB, LaMalfa KS, Blough BE,

    PAL-335

    PAL-335

  • 2-MAPB
  • Chemical compound

    As with other related substituted benzofuran derivatives such as 6-APB and 5-MAPB, 2-MAPB is a monoamine releaser with some selectivity for serotonin release

    2-MAPB

    2-MAPB

    2-MAPB

  • Amfepramone
  • Stimulant drug used as an appetite suppressant

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Amfepramone

    Amfepramone

    Amfepramone

  • Methylone
  • Entactogen drug

    serotonin 5-HT1A, 5-HT1B, and 5-HT1D receptors. In contrast to MDMA however, methylone and its metabolites lack significant affinity for the serotonin 5-HT2A

    Methylone

    Methylone

    Methylone

  • Clominorex
  • Chemical compound

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Clominorex

    Clominorex

    Clominorex

  • MDM1EA
  • Pharmaceutical compound

    (3T-MDMA; MY100) MY101 MY200 Indanes Amphetamines: 5-APDI (IAP) 5-MAPDI (IMP) Indoles Amphetamines: 5-API (5-IT; PAL-571) 6-API (6-IT) Naphthalenes Amphetamines:

    MDM1EA

    MDM1EA

    MDM1EA

  • MYCO-006
  • Pharmaceutical compound

    chemical structure of MYCO-006 does not yet appear to have been disclosed. 5-BZT-MDMA and 6-BZT-MDMA were described in Mydecine's patent for short-acting

    MYCO-006

    MYCO-006

  • Psilocin
  • Psychedelic drug

    the serotonin 5-HT2A receptor among others. The drug produces its hallucinogenic effects specifically via activation of the serotonin 5-HT2A receptor

    Psilocin

    Psilocin

    Psilocin

  • 5-APB
  • Entactogen

    5-APB, also known as 5-(2-aminopropyl)benzofuran, is an entactogen of the phenethylamine, amphetamine, and benzofuran families. 5-APB and related drugs

    5-APB

    5-APB

    5-APB

  • Amphetamine
  • Central nervous system stimulant

    amphetamine treatment for ADHD in children that found an average increase of 4.5 IQ points, continued increases in attention, and continued decreases in disruptive

    Amphetamine

    Amphetamine

    Amphetamine

  • 4-Hydroxyamphetamine
  • Group of stereoisomers

    the serotonin 5-HT2A receptor and that they are mediated by induction of serotonin release as opposed to direct agonism of the serotonin 5-HT2A receptor

    4-Hydroxyamphetamine

    4-Hydroxyamphetamine

    4-Hydroxyamphetamine

  • Fenfluramine/phentermine
  • Withdrawn anti-obesity drug combination

    it only temporarily reduced weight. A 1984 study found a weight loss of 7.5 kg on average in 24 weeks, as compared to 4.4 kg under placebo. It sold modestly

    Fenfluramine/phentermine

    Fenfluramine/phentermine

    Fenfluramine/phentermine

  • Trifluoromethylaminoindane
  • Chemical compound

    5-Trifluoromethyl-2-aminoindane (TAI) is a drug of the 2-aminoindane family with putative entactogenic effects. It acts as a serotonin releasing agent

    Trifluoromethylaminoindane

    Trifluoromethylaminoindane

    Trifluoromethylaminoindane

  • 4-Fluoroamphetamine
  • Psychoactive research chemical

    serotonin 5-HT2A receptor (Ki = 11,300 nM) and serotonin 5-HT2C receptor (Ki = 7,800 nM), similar to that of MDMA in the case of the serotonin 5-HT2A receptor

    4-Fluoroamphetamine

    4-Fluoroamphetamine

    4-Fluoroamphetamine

  • EDMA
  • Chemical compound

    Compared to MDMA, EDMA was about half as potent as a serotonin releaser, 4.5-fold less potent as a norepinephrine releaser, and 8-fold less potent as a

    EDMA

    EDMA

    EDMA

  • Levoamphetamine
  • CNS stimulant and isomer of amphetamine

    However, time to peak levels was delayed from 2.5 hours (range 1.5–6 hours) to 4.5 hours (range 2.5–8.0 hours). During oral selegiline therapy at a dosage

    Levoamphetamine

    Levoamphetamine

    Levoamphetamine

  • 5-Chloro-αMT
  • Chemical compound

    5-Chloro-αMT, also known as 5-chloro-α-methyltryptamine or as PAL-542, is a tryptamine derivative related to α-methyltryptamine (αMT) and one of only

    5-Chloro-αMT

    5-Chloro-αMT

    5-Chloro-αMT

  • 5-Methoxymethylone
  • Chemical compound of the cathinone class

    5-Methoxymethylone (also known as 2-A1MP and βk-MMDMA) is a chemical compound of the cathinone class which has been sold online as a designer drug. It

    5-Methoxymethylone

    5-Methoxymethylone

    5-Methoxymethylone

  • Norepinephrine transporter
  • Protein-coding gene in the species Homo sapiens

    paralyzing the normal function of the NET. At the same time, higher levels of 5-HT are maintained in the synapse increasing the concentrations of the latter

    Norepinephrine transporter

    Norepinephrine transporter

    Norepinephrine_transporter

  • List of dopaminergic drugs
  • yl)-2β-(3'-phenylisoxazol-5'-yl)nortropane (FE-β-CPPIT) • N-(3'-Fluoropropyl-)-3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)nortropane (FP-β-CPPIT) •

    List of dopaminergic drugs

    List of dopaminergic drugs

    List_of_dopaminergic_drugs

  • MYCO-002
  • Pharmaceutical compound

    (3T-MDMA; MY100) MY101 MY200 Indanes Amphetamines: 5-APDI (IAP) 5-MAPDI (IMP) Indoles Amphetamines: 5-API (5-IT; PAL-571) 6-API (6-IT) Naphthalenes Amphetamines:

    MYCO-002

    MYCO-002

  • Heptaminol
  • Chemical compound

    Piperazines: 2C-B-BZP BZP MBZP MDBZP MeOPP oMPP Others: 2-ADN 2-AI 2-AT 4-BP 5-APDI 5-IAI Amineptine Clofenciclan Cyclopentamine Cypenamine Cyprodenate Feprosidnine

    Heptaminol

    Heptaminol

  • Vesicular monoamine transporter 2
  • Mammalian protein found in Homo sapiens

    monoamines and acetylcholine". Pflügers Archiv. 447 (5): 636–640. doi:10.1007/s00424-003-1100-5. PMID 12827358. S2CID 20764857. Tritsch NX, Ding JB, Sabatini

    Vesicular monoamine transporter 2

    Vesicular monoamine transporter 2

    Vesicular_monoamine_transporter_2

Searches for online references containing 5 APDI

5 APDI

Search references containing 5 APDI

5 APDI

Search queries for Facebook and twitter posts, hashtags with 5 APDI

5 APDI

Follow users with usernames @5 APDI or posting hashtags containing #5 APDI

5 APDI

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with 5 APDI

5 APDI

Top search, Social media, medium, facebook & news articles containing 5 APDI

5 APDI

Searches for Acronyms & meanings containing 5 APDI

5 APDI

Searches, Indeed job searches and job offers containing 5 APDI

Other words and meanings similar to

5 APDI

Search in online dictionary sources & meanings containing 5 APDI

5 APDI